Tonix Pharmaceuticals Holding Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

SALE OF COMMON STOCK (Details Narrative)

SALE OF COMMON STOCK (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands										12 Months Ended		15 Months Ended
	Dec. 13, 2018	Dec. 11, 2018	Dec. 07, 2018	Oct. 18, 2018	May 01, 2018	Sep. 28, 2017	Apr. 13, 2017	Apr. 04, 2017	Mar. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018
Number of options granted										101,968	26,000
Gross proceeds from stock issuance										$ 12,714	$ 18,505
Beneficial conversion feature in connection with sale of Series A Convertible preferred stock and deemed dividend										$ 3,266
Series A Convertible Preferred Stock [Member]
Issuance of Series A Convertible preferred stock and common stock warrants in December 2018 (in shares)										11,984
Conversion of preferred stock (shares)										2,128
Shares issue upon conversion of preferred stock (shares)										608,000
Purchase Agreement and Registration Rights Agreement [Member] \| Lincoln Park Capital Fund, LLC ("Lincoln Park") [Member]
Commitment to purchase shares under agreement				$ 15,000,000		$ 15,000,000
Issuance of common stock for commitment to purchase				$ 245		$ 300,000
Issuance of common stock for commitment to purchase (shares)				35,000		7,304
Limitation on sale of common shares outstanding (percent)						19.99%
Limitation on sale of common shares outstanding (shares)						150,000
Underwriting Agreement [Member] \| Alliance Global Partners Dawson And James Securitie Inc [Member] \| Class A Units [Member]
Share price (in dollars per share)			$ 3.50
Number of common shares per unit			1
Number of warrants to purchase to common stock per unit			1
Underwriting Agreement [Member] \| Class A Units [Member] \| Alliance Global Partners Dawson And James Securitie Inc [Member]
Issuance of common stock and common stock warrants in December 2018 (in shares)			861,710
Number of options granted			642,856
Number of options granted, term			45 days
Number of warrants granted			642,856
Underwriting Agreement [Member] \| Class B Units [Member] \| Alliance Global Partners Dawson And James Securitie Inc [Member]
Issuance of Series A Convertible preferred stock and common stock warrants in December 2018 (in shares)			11,984
Share price (in dollars per share)			$ 1,000
Number of warrants to purchase to common stock per unit			285.7143
Number of convertible preferred stock per unit			1
Warrants expiration period			5 years
Conversion price per share			$ 3.50
Underwriting Agreement [Member] \| Over-Allotment Option [Member] \| Alliance Global Partners Dawson And James Securitie Inc [Member]
Number of shares issued	250,000
Net proceeds from issuance of common stock	$ 800
Underwriting discount	$ 100
Underwriting discount per share (in dollars per share)	$ 0.24
Beneficial conversion feature in connection with sale of Series A Convertible preferred stock and deemed dividend	$ 3,300
Underwriting Agreement [Member] \| Over-Allotment Option [Member] \| Class A Units [Member] \| Alliance Global Partners Dawson And James Securitie Inc [Member]
Number of shares issued		640,000
Net proceeds from issuance of common stock		$ 6
Underwriting Agreement [Member] \| Public Offering [Member] \| Class A Units [Member] \| Alliance Global Partners Dawson And James Securitie Inc [Member]
Net proceeds from issuance of common stock		13,600
Underwriting discount		$ 1,100
Underwriting discount per share (in dollars per share)		$ 0.24
Discount to the public offering price		7.00%
Underwriting discount and other offering expenses		$ 400
Underwriting Agreement [Member] \| Underwriters (2017 Underwriters) [Member] \| April 2017 Financing [Member]
Common shares to be offered under agreement (shares)									180,000
Share price (in dollars per share)									$ 44.50
Net proceeds from issuance of common stock								$ 7,200
Underwriting discount								$ 600
Underwriting discount per share (in dollars per share)								$ 3.12
Offering expenses								$ 200
Percentage of underwriting discount								7.00%
Underwriting Agreement [Member] \| Underwriters (2017 Underwriters) [Member] \| Over-Allotment Option [Member]
Number of options granted									27,000
April2017FinancingMember \| Underwriters (2017 Underwriters) [Member] \| Over-Allotment Option [Member]
Number of shares issued							270,000
Net proceeds from issuance of common stock							$ 1,100
Underwriting discount							$ 100
Underwriting discount per share (in dollars per share)							$ 3.12
2016 Sales Agreement [Member] \| Cowen and Company LLC [Member] \| At-The-Market Offering [Member]
Offering price per agreement											$ 15,000
Number of shares issued											149,000
Net proceeds from issuance of common stock											$ 9,100
Payment of commision											$ 300
Sales Agreement [Member] \| Cowen and Company LLC [Member] \| At-The-Market Offering [Member]
Offering price per agreement					$ 9,500
Number of shares issued										593,000
Net proceeds from issuance of common stock										$ 6,900
Percentage of selling commission					3.00%
Payment of commision										$ 200
2017 Purchase Agreement [Member] \| Lincoln Park Capital Fund, LLC ("Lincoln Park") [Member]
Number of shares issued										118,000		143,000
Gross proceeds from stock issuance										$ 2,400		$ 3,500